Buys
Open market- Shares
- Avg price
- Total value
Veronica Sanchez Bulis - VP, Corporate Controller at Lyell Immunopharma, Inc.
Issuer-level insider activity
- Role
- VP, Corporate Controller
- Issuer ticker
- LYEL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Veronica Sanchez Bulis in Lyell Immunopharma, Inc.
Sells
Open market- Shares
- -2,782
- Avg price
- $31.63
- Total value
- -$88,004
Net
Past year- Shares
- -2,782
- Share %
- -100%
- Total value
- -$88,004
Reported holdings for Veronica Sanchez Bulis in Lyell Immunopharma, Inc.
Form 4 holding
VP, Corporate Controller
Lyell Immunopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 15,420
- Estimated value
- $291,592
- Report date
- 11 May 2026
- Price
- $18.91
- Ownership
- Direct
Transaction history for Veronica Sanchez Bulis in Lyell Immunopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.